Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/2/2024
Publication Announcement on the Inclusion of Marstacimab as Pilot Proj...
10/1/2024
HUTCHMED Announces Japan Approval for FRUZAQLA (fruquintinib) Received...
10/1/2024
InventisBio Prevails in Trade Secret Misappropriation Lawsuit Filed by...
10/1/2024
Alphamab and CSPC Enter a Licensing Deal on Anti-HER2 BsADC JSKN003 in...
10/1/2024
Akeso's Ebronucimab (PCSK9) Approved for Hypercholesterolemia in China
10/1/2024
Biotheus to Initiate Phase 3 Trial of BsAb PM8002 for SCLC
10/1/2024
Regeneron and Sanofi Announced Chinese Approval of Dupixent as the Fir...
10/1/2024
MediLink Registers Phase 3 Trial of Its B7H3 ADC YL201
10/1/2024
Lepu Biopharma Files NDA for Lead Product EGFR ADC MRG003
10/1/2024
Akeso's Cadonilimab Receives Second Indication Approval from NMPA
10/1/2024
Haleon Plans to Raise Stake in Chinese JV to 88%
10/1/2024
AFT in China License Deal with Xizang Weixinkang Pharma for Maxigesic ...
10/1/2024
China's Pharmaceutical Antimonopoly Guidelines Pose New Challenges for...
9/27/2024
Recent Executive Moves
9/27/2024
TJ Biopharma Secures €213M Deal with Sanofi for Greater China Rights ...
9/27/2024
Junshi Announces EC Approval of Toripalimab
9/23/2024
Is Biotech the Next Battleground in US-China Decoupling? (SCMP)
9/20/2024
Another Twist in the Biosecure Drama Leaves Bill's Fate Uncertain
9/20/2024
Why 'Big Pharma' Will be the Next China Trade War Battleground (Invest...
9/20/2024
Ocumension Therapeutics's ZERVIATE Approved in China
9/20/2024
NMPA Deputy Commissioner Meets with Danish Delegation
9/20/2024
Recent Executive Moves
9/19/2024
Kite Sells Stake in Fosun JV, Giving Chinese Partner Full Control of C...
9/19/2024
China's Implementation of Patent Term Adjustment (SM)
9/17/2024
NHC's Annual Statistical Report on China Healthcare Sector Development...
9/17/2024
Biopharma Prepares to Pivot from China as Biosecure Act Advances (Phar...
9/17/2024
NHSA Announces Conclusion of Expert Evaluation for 2024 DRDL Inclusion...
9/13/2024
NHSA and MOF Jointly Issue Reform Policies Relatinng to Direct Settlem...
9/13/2024
Organon Enters into China Licensing Deal for Fertility Asset with Bao ...
9/13/2024
IQVIA: Chinese Hospital Drug Market Down 0.2% in MAT Q2/2024
Page:
18
/
354
Total number of articles:
10618
:
[First]
[<<]
[16]
[17]
[18]
[19]
[20]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit